Arapahoe Launches Med-Free Incentive

Colorado track will reward those who race and win medication-free.

Press Release

Arapahoe Park has launched an innovated medication incentive program.

Arapahoe Park will reward horsemen who do not administer race-day medication to their horses with the creation of the Race-Day Medication-Free Incentive.

The Aurora, Colorado, racecourse will introduce the incentive program for all races beginning Friday, June 27.  Trainers who win a race with a horse void of any race-day medication will receive a $1,000 bonus per victory to be paid from a special fund created by Arapahoe Park.

Race-Day Medication-Free Incentive is being launched to encourage trainers to go beyond the letter of the law that permits only Lasix, phenylbutazone (“bute”), flunixin, and ketoprofen on race day in Colorado.

“The future of racing is going to be race-day medication-free, and we at Arapahoe Park want to be ahead of the curve,” said Bruce Seymore, Executive Director of Mile High Racing and Entertainment, the parent company of Arapahoe Park.  “We in Colorado already have one of the strictest testing procedures in the country. This new Race-Day Medication-Free Incentive allows us to continue to improve our standards.”

Trainers must be stabled at Arapahoe Park for the entire meet to be eligible for the bonuses. The bonuses will be paid out at the end of the season that concludes on August 17.

AQHA News and information is a service of the American Quarter Horse Association. For more news and information,
follow @AQHARacing on Twitter, watch the AQHA Racing Newscast and visit